NRXS Competitors & Alternatives
Compare Neuraxis, Inc. with similar stocks in the same industry
Biotechnology
NRXS
Main Stock$7.00
Tradestie Score
54
Market Cap
$30.70M
Revenue Growth
0.8%
Analyst Upside
+57.1%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences, Inc.
|
$5.01
|
$158.43M | - | 53 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.30
|
$133.50M | - | 66 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.39
|
$114.01M | - | 58 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.44
|
$110.20M | - | 61 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$29.19
|
$76.55M | - | 51 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.77
|
$71.69M | - | 64 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$9.91
|
$67.94M | - | 59 | Compare |
|
XLO
Xilio Therapeutics, Inc. Common Stock
|
$8.90
|
$43.15M | - | 54 | Compare |
|
SHFS
SHF Holdings, Inc. Class A Common Stock
|
$0.24
|
$21.61M | - | 43 | Compare |
|
ACXP
Acurx Pharmaceuticals, Inc. Common Stock
|
$1.42
|
$7.29M | - | 51 | Compare |
More NRXS Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 3845)
230 stocks in this industry